RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2018, it operated 11 hospitals and 5,369 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+49-9-771650
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.43 billion
Profitability
Miscellaneous
Employees9,384
Next Earnings Date8/1/2019 (Estimated)
OptionableNot Optionable
Rhoen Klinikum (ETR:RHK) Frequently Asked Questions
What is Rhoen Klinikum's stock symbol?
Rhoen Klinikum trades on the ETR under the ticker symbol "RHK."
When is Rhoen Klinikum's next earnings date?
What price target have analysts set for RHK?
7 equities research analysts have issued 1 year price targets for Rhoen Klinikum's shares. Their forecasts range from €16.50 to €27.00. On average, they anticipate Rhoen Klinikum's stock price to reach €22.17 in the next twelve months. This suggests that the stock has a possible downside of 13.2%. View Analyst Price Targets for Rhoen Klinikum.
What is the consensus analysts' recommendation for Rhoen Klinikum?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rhoen Klinikum in the last year. There are currently 4 sell ratings and 3 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rhoen Klinikum.
Has Rhoen Klinikum been receiving favorable news coverage?
Headlines about RHK stock have trended very negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rhoen Klinikum earned a daily sentiment score of -3.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
Who are some of Rhoen Klinikum's key competitors?
Some companies that are related to Rhoen Klinikum include NMC Health (NMC), Mediclinic International (MDC), Healius (HLS), Greencross (GXL), Spire Healthcare Group (SPI), CareTech (CTH), Virtus Health (VRT), Georgia Healthcare Group (GHG), Pacific Smiles Group (PSQ), Assure (IOM), CENTRIC HEALTH (CHH), Konekt (KKT), Brain Resource (BRC), Nobilis Health (HLTH) and Totally (TLY).
What other stocks do shareholders of Rhoen Klinikum own?
Who are Rhoen Klinikum's key executives?
Rhoen Klinikum's management team includes the folowing people:
- Mr. Stephan Holzinger, Chairman of Board of Management & CEO
- Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management
- Dr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)
- Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)
- Julian Schmitt, Head of Investor Relation
What is Rhoen Klinikum's stock price today?
One share of RHK stock can currently be purchased for approximately €25.55.
How big of a company is Rhoen Klinikum?
Rhoen Klinikum has a market capitalization of $1.71 billion and generates $1.43 billion in revenue each year. Rhoen Klinikum employs 9,384 workers across the globe.
What is Rhoen Klinikum's official website?
How can I contact Rhoen Klinikum?
Rhoen Klinikum's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.
MarketBeat Community Rating for Rhoen Klinikum (ETR RHK)
MarketBeat's community ratings are surveys of what our community members think about Rhoen Klinikum and other stocks. Vote "Outperform" if you believe RHK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHK will underperform the S&P 500 over the long term. You may vote once every thirty days.
